These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7639818)
1. Effect of patient population characteristics in assessing the efficacy and toxicity of methotrexate in rheumatoid arthritis: comment on the article by Weinblatt et al. Porter D; Capell H Arthritis Rheum; 1995 Aug; 38(8):1173-4. PubMed ID: 7639818 [No Abstract] [Full Text] [Related]
2. Reconsideration of the effects of methotrexate therapy on radiographic progression in rheumatoid arthritis: comment on the article by Weinblatt et al. Roces A; Cantabrana A; Hayek M; Dávila M Arthritis Rheum; 1994 Jul; 37(7):1114. PubMed ID: 8024623 [No Abstract] [Full Text] [Related]
3. Effect of folic acid supplementation on the efficacy of methotrexate treatment in rheumatoid arthritis: comment on the article by Khanna et al. Morgan SL; Baggott JE; Alarcón GS Arthritis Rheum; 2006 May; 54(5):1708-9; author reply 1709-10. PubMed ID: 16646062 [No Abstract] [Full Text] [Related]
4. Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al. Fries JF; Ramey DR; Singh G Arthritis Rheum; 1994 Dec; 37(12):1829-30. PubMed ID: 7986233 [No Abstract] [Full Text] [Related]
5. Association of methotrexate effects and single-nucleotide polymorphisms in the folate pathway in rheumatoid arthritis: comment on the article by Wessels et al. Ranganathan P Arthritis Rheum; 2006 Oct; 54(10):3372; author reply 3372-3. PubMed ID: 17009311 [No Abstract] [Full Text] [Related]
6. Reponse to methotrexate and reduced mortality in patients with rheumatoid arthritis: comment on the article by Krause et al. Alarcón GS Arthritis Rheum; 2000 Aug; 43(8):1902-3. PubMed ID: 10943886 [No Abstract] [Full Text] [Related]
7. Monitoring guidelines for methotrexate-treated rheumatoid arthritis patients: comment on the article by Yazici et al. Alarcón GS; Kremer J; Weinblatt M Arthritis Rheum; 2004 Aug; 50(8):2710; author reply 2710-1. PubMed ID: 15334490 [No Abstract] [Full Text] [Related]
8. Creating a care-effective cost-effective strategy for methotrexate liver toxicity monitoring in rheumatoid arthritis: comment on the article by Kremer et al. Newman ED; Harrington TM; Perruquet JL; Davis DE; Torretti D Arthritis Rheum; 1995 Feb; 38(2):297-8. PubMed ID: 7848325 [No Abstract] [Full Text] [Related]
9. Methotrexate and lung disease in rheumatoid arthritis: comment on the article by Conway et al. Rojas-Serrano J; Mateos-Toledo H; Mejía M Arthritis Rheumatol; 2014 Sep; 66(9):2641-2. PubMed ID: 24909129 [No Abstract] [Full Text] [Related]
10. Effect of golimumab combined with methotrexate on radiographic progression in rheumatoid arthritis: comment on the article by Emery et al. Graudal N; Jürgens G Arthritis Rheum; 2012 Apr; 64(4):1297-8; author reply 1298-9. PubMed ID: 22231914 [No Abstract] [Full Text] [Related]
11. Leucovorin versus folic acid in the treatment of methotrexate toxicity: comment on the article by Shiroky et al. Morgan SL; Baggott JE; Alarcón GS; Koopman WJ; Krumdieck CL Arthritis Rheum; 1994 Mar; 37(3):444-5. PubMed ID: 8155177 [No Abstract] [Full Text] [Related]
12. Results of controlled study of combination therapy with azathioprine and methotrexate in the treatment of rheumatoid arthritis revisited: comment on the article by Willkens et al. McCarty DJ Arthritis Rheum; 1996 Aug; 39(8):1436-7. PubMed ID: 8702460 [No Abstract] [Full Text] [Related]
13. The effects of methotrexate on soluble interleukin-2 receptor levels in rheumatoid arthritis: comment on the article by Barrera et al. Crilly A; Madhok R Arthritis Rheum; 1994 Apr; 37(4):597-9. PubMed ID: 8147940 [No Abstract] [Full Text] [Related]
14. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis: comment on the article by Gutierrez-Ureña et al. Berthelot JM; Maugars Y; Prost A Arthritis Rheum; 1997 Jan; 40(1):193-4; author reply 195-6. PubMed ID: 9008619 [No Abstract] [Full Text] [Related]
15. Auranofin, methotrexate, but no placebo: comment on the article by Williams et al. Epstein WV; Criswell LA Arthritis Rheum; 1992 Nov; 35(11):1406-7. PubMed ID: 1445469 [No Abstract] [Full Text] [Related]
16. Incidence of pancytopenia with methotrexate treatment of rheumatoid arthritis in Germany: comment on the article by Gutierrez-Ureña et al. Kassai A; Rautenstrauch H Arthritis Rheum; 1997 Jan; 40(1):195-6. PubMed ID: 9008621 [No Abstract] [Full Text] [Related]
17. Issues in the study of azathioprine, methotrexate, and combination therapy: comment on the article by Willkens et al. Madhok R; Menon N Arthritis Rheum; 1993 Aug; 36(8):1183-4. PubMed ID: 8343195 [No Abstract] [Full Text] [Related]
18. Comment on Pavy et al.'s original article "Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion". Kuek A; Ostör AJ Joint Bone Spine; 2007 Mar; 74(2):212-3; author reply 213. PubMed ID: 17350310 [No Abstract] [Full Text] [Related]
19. Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort. Owen SA; Lunt M; Hider SL; Bruce IN; Barton A; Thomson W Arthritis Rheum; 2010 Dec; 62(12):3827-9. PubMed ID: 20848569 [No Abstract] [Full Text] [Related]
20. Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al. Riksen NP; Rongen GA; Smits P; van Riel P; Barrera P Arthritis Rheum; 2007 Feb; 56(2):694; author reply 694-5. PubMed ID: 17265507 [No Abstract] [Full Text] [Related] [Next] [New Search]